他汀类药物用于成人首次静脉血栓栓塞性疾病发作

Statins for adults with a first episode of venous thromboembolic disease

作者信息Héctor José Peroni, Sabrina Rico, Camila Micaela Escobar Liquitay, Luis Garegnani
PMID42886002
发布时间2026-10-16
DOI10.1002/14651858.CD016403

实验完整度

低

本文为Cochrane系统综述方案,未开展原始实验,无实验方法与验证结果

摘要

This is a protocol for a Cochrane review (intervention). The objectives are as follows: To evaluate the benefits and harms of statins in the secondary prevention of Recurrent Venous ThromboEmbolic disease (RVTE): Deep Vein Thrombosis (DVT), Pulmonary ThromboEmbolism (PTE) and Post-Thrombotic Syndrome (PTS) in patients with a first episode of deep vein thrombosis Secondary objective To evaluate the benefits and harms of statins in the secondary prevention of RVTE, DVT, PTE and PTS in patients with or without cancer, in different sexes and in the general population aged over 70 years.

实验结论

提炼研究问题、关键发现与证据,快速把握文章的核心贡献。

研究问题
他汀类药物用于首次深静脉血栓形成患者复发性静脉血栓栓塞性疾病(RVTE)、深静脉血栓形成(DVT)、肺血栓栓塞(PTE)和血栓后综合征(PTS)的二级预防,其获益与危害如何?
核心机制
文中未明确说明
主要证据
文中未明确说明
研究意义
文中未明确说明